M. Agarwal a.o.: The p53 network. J. Biol. Chem. 273 (1998), 1-4. M. Bennett/G. Evan/S. Schwartz: Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res. 77 (1995), 266-... 9005 James Bischoff a.o.: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 18 October 1996, 373-376. C. Canman a.o.: Growth factor modulations of p53-mediated growth arrest versus apoptosis. Genes Dev. 9 (1995), 600-... 13005 Antony Carr: Piecing together the p53 puzzle. Science 10 March 2000, 1765-1766. Vincenzo Chiarugi/Marco Ruggieri: Role of three cancer <> p53, bcl2 and c-myc on the apoptotic process. Tumori 82/3 (1996), ... Abstract: "We review some of the most recent developments concerning three genes involved in human cancer: p53, bcl2 and c-myc. Recent data have demonstrated that the bcl2 gene protects tumor cells from apoptosis induced by a variety of agents, including ionizing radiation, and is thus related to resistance to DNA-damaging therapeutic agents. The p53 tumor suppressor gene, however, has been related with growth arrest, apoptosis and thus with selective sensitivity to the killing effects of ionizing radiation and DNA-damaging drugs. This functional antagonism between the two genes was recently substantiated in molecular terms by demonstration of reciprocal down- regulation due to the presence of a p53-dependent transcription silencer in the untranslated region of the bcl2 gene. Growth arrest in the G1 phase of the cell cycle and induction of apoptosis are two distinct and dissectable functions of p53: bcl2 is able to antagonize the induction of apoptosis by p53, but not the growth arrest in G1. However, coexpression of bcl2 and of the oncogene c-myc efficiently antagonizes effects on G1 arrest and apoptosis, thus suggesting a cooperation between the two oncogenes. In addition, c-myc disrupts other functions of genetic control in the early G1 phase of the cell cycle including the expression of D1 cyclin. We believe that knowledge of the functional/molecular interactions between these three genes involved in human cancer is a fundamental prerequisite to improve the knowledge on prognosis and to design innovative therapeutic approaches." J. Cleveland a.o.: v-Raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene 9 (1994), 2217-... M. Debbas/E. White: Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7 (1993), 546-... L. Diller a.o.: p53 functions as a cell cycle control protein in osteosarcoma. Mol. Cell. Biol. 10 (1990), 5772-5781. L. Donehower/L. Godley/C. Aldaz: Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9 (1995), 882-... W. El-Deiry a.o.: WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993), 817-825. C. Finlay/P. Hinds/A. Levine: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57 (1989), 1083-... 15445 Tanya Gottlieb/Moshe Oren: p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287 (1996), 77-102. 14858 Michael Gros'': p53 - Selbstmordknopf fu''r defekte Zellen. Spektrum 2000/11, 14. 9003 Peter Hall/David Lane: p53 - a developing role? Internet 1997. C. Harris/M. Hollstein: Clinical implications of the p53 tumor-suppressor gene. New England J. Med. 329 (1993), 1318-... Y. Haupt a.o.: Induction of apoptosis in HeLa cells by transactivation- deficient p53. Genes Dev. 9 (1995), 2170-... P. Hinds/R. Weinberg: Tumor suppressor genes. Curr. Op. Gen. Dev. 4 (1994), 135-141. 13044 Atsushi Hirao a.o.: DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 10 March 2000, 1824-1827. K. Howes a.o.: Apoptosis or retinoblastoma - alternative facets of photoreceptors expressing the hpv-16 E7 gene in the presence or absence of p53. Genes Dev. 8 (1994), 1300-... M. Kastan a.o.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 (1992), 587-597. C. Kemp/L. Donehower/A. Bradley/A. Balmain: Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74 (1993), 813-822. 16444 Anshul Kundaje/Shane Eisenman: Modeling of the p53 pathway to cell cycle arrest and apoptosis - relevance to cancer. Internet 2001, 19p. 8790 Paul Kussie a.o.: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 8 November 1996, 948-953. D. Lane: Worrying about p53. Curr. Biol. 2 (1992), 581-583. J. Lee/J. Abrahamson/A. Bernstein: DNA damage, oncogenesis and the p53 tumour-suppressor gene. Mutat. Res. 307 (1994), 573-... H. Lin a.o.: Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell Biol. 15 (1995), 4536-... X. Liu/C. Miller/P. Koeffler/A. Ber: The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13 (1993), 3291-3300. L. Livingstone a.o.: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 (1992), 923-935. S. Lowe a.o.: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Nat. Ac. Sci. USA 91 (1994), 2026-... S. Lowe a.o.: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 (1993), 957-... S. Lowe a.o.: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 (1993), 847-... X. Lu/D. Lane: Differential induction of transcriptionally active p53 following UV or ionizing radiation - defects in chromosome instability syndromes? Cell 75 (1993), 765-... I. Magrisso a.o.: Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab. Invest. 69 (1993), 674-... D. Malkin a.o.: Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 (1990), 1233-... 11490 Marty Mayo a.o.: Requirement of NF-kappaB activatioon to suppress p53-independent apoptosis induced by oncogenic rats. Science 5 December 1997, 1812-1815. W. Mercer: Cell cycle regulation and the p53 tumor suppressor protein. Crit. Rev. Eukaryot. Gene Expr. 2 (1992), 251-263. 13658 Richard Morrison/Yoshito Kinoshita: p73 - guilt by association? Science 14 July 2000, 257-258. p53 has been found to have two close relatives, p63 and p73. T. Miyashita/J. Reed: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995), 293-... 13435 Eri Oda a.o.: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 12 May 2000, 1053-1058. 6171 Jonathan Oliner: The role of p53 in cancer development. Science & Medicine 1/4 (1994), 16-25. The gene p53 is mutated in nearly half of all cancers. The statistics imply that mutating p53 affords a strong selective growth advantage to tumor cells of almost every type. Jonathan Oliner: Discerning the function of p53 by examining its molecular interactions. BioEssays 15 (1993), 703-707. 8791 Elizabeth Pennisi: Filling in the blanks in the p53 protein structure. Science 8 November 1996, 921-922. M. Perry/A. Levine: Tumor suppressor p53 and the cell cycle. Curr. Op. Gen. Devel. 3 (1993), 50-54. C. Prives: Doing the right thing - feedback control and p53. Curr. Op. Cell Biol. 5 (1993), 214-... X. Qin a.o.: Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Nat. Ac. Sci. USA 91 (1994), 10918-... 9006 Michael Rebhan: p53 tumor suppressor. Internet 1996. D. Reisman a.o.: c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Diff. 4 (1993), 57-... S. Rong a.o.: Met protooncogene product is overexpressed in tumors of p53 deficient mice and tumors of Li-Fraumeni patients. Cancer Res. 55 (1995), 1963-... P. Sabbatini a.o.: Essential role for p53-mediated transcription in E1A- induced apoptosis. Genes Dev. 9 (1995), 2184-... A. Sands/L. Donehower/A. Bradley: Gene-targeting and the p53 tumor-suppressor gene. Mutat. Res. 307 (1994), 557-... M. Smith a.o.: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266 (1994), 1376-... H. Symonds a.o.: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 (1994), 703-... Bert Vogelstein/Kenneth Kinzler: p53 function and dysfunction. Cell 70 (1992), 523-526. 15440 Karen Vousden: Activation of the p53 tumor suppressor protein. Biochi. Biophys. Atta 1602 (2002), 47-59. B. Werness/A. Levine/P. Howley: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990), 76-... Y. Yin a.o.: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70 (1992), 937-948. 9002 ZZ: Articles on p53. Internet, ca. 1995. 9004 ZZ: Tumor protein p53. Internet, ca. 1995. 9001 ZZ: p53-derived peptides might be targets for tumor immunotherapy. Internet 1996. 13271 ZZ: A perpetrator of p53-dependent apoptosis. Science 14 April 2000, 231.